Replies to post #175269 on Biotech Values

[pollyvonwog]

I'm with genisi in attributing the sharp decline to thrice-weekly. The sell-siders also jumped on this. However, I do think it will scale back some once the generic hits and would be surprised if it ever hits the 30% mark.